SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Cerity Partners LLC

Cerity Partners LLC trimmed its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 24.1% in the fourth quarter, HoldingsChannel.com reports. The firm owned 62,438 shares of the exchange traded fund’s stock after selling 19,810 shares during the quarter. Cerity Partners LLC’s holdings in SPDR S&P Biotech ETF were worth $5,575,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Verity Asset Management Inc. lifted its position in shares of SPDR S&P Biotech ETF by 7.9% during the 3rd quarter. Verity Asset Management Inc. now owns 17,228 shares of the exchange traded fund’s stock valued at $1,258,000 after acquiring an additional 1,266 shares during the last quarter. Prime Capital Investment Advisors LLC raised its stake in SPDR S&P Biotech ETF by 52.6% during the 4th quarter. Prime Capital Investment Advisors LLC now owns 6,464 shares of the exchange traded fund’s stock valued at $577,000 after purchasing an additional 2,228 shares during the period. United Capital Management of KS Inc. raised its stake in SPDR S&P Biotech ETF by 1.8% during the 4th quarter. United Capital Management of KS Inc. now owns 104,048 shares of the exchange traded fund’s stock valued at $9,290,000 after purchasing an additional 1,831 shares during the period. International Assets Investment Management LLC acquired a new stake in SPDR S&P Biotech ETF during the 4th quarter valued at $10,587,000. Finally, Albion Financial Group UT acquired a new stake in SPDR S&P Biotech ETF during the 4th quarter valued at $69,000.

SPDR S&P Biotech ETF Stock Down 0.8 %

Shares of NYSEARCA:XBI opened at $85.62 on Wednesday. The company’s fifty day moving average is $93.86 and its two-hundred day moving average is $84.12. SPDR S&P Biotech ETF has a 12-month low of $63.80 and a 12-month high of $103.52. The company has a market cap of $6.65 billion, a P/E ratio of 11.47 and a beta of 1.08.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.